Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACADIA Pharmaceuticals Inc (ACAD) -- Ignore unavailable to you. Want to Upgrade?

To: dr.praveen who wrote (395)	3/19/2007 3:51:28 PM
From: Ian@SI	Respond to of 588

Thanks, makes good sense. If ACAD trades another 3M shares in the next 10 minutes, then it will have turned over the entire public float today. Amazing! Ian

To: dr.praveen who wrote (395)	3/20/2007 12:54:25 PM
From: tuck	Read Replies (1) \| Respond to of 588

Praveen, I agree. Further, the improvement in weight gain is not broken out, so I gather it is not dramatic. Also, the comparison against haloperidol is not as good, and it's generic. Will the faster onset of action (also not broken out) and (probably) minor improvement in weight be enough to convince insurers to pay a lot more? I have my doubts. The stock is looking strong today again, and I am looking to exit my Mom's position on this strength. I also have doubts about 104, and as you say, PIII for 103 is a ways away. Edit: Over 2.5 million shares short, heh, heh. This is one where they deserve to be roasted. A few days ago, that yielded a short ratio of 15+, but with the volume we're seeing, they could have covered (for large losses unless their timing was good on entry (i.e. when Cramer was pumping it)) by now. Cheers, Tuck